Month: August 2014

Uncategorized Published - 5 August, 2014    By - Dr. Clemens
FDA Approves Abuse-Deterrent Oxycodone/Naloxone Combo

The US Food and Drug Administration (FDA) has approved an abuse-deterrent extended-release formulation of oxycodone (Targiniq ER, Purdue Pharma LP), a combination of oxycodone hydrochloride and naloxone hydrochloride, the agency announced today. The new formulation is approved to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment, for which alternative treatment options are […]

Read More
Uncategorized Published - 5 August, 2014    By - Dr. Clemens
Slower U.S. Healthcare Cost Rise Extending Life of Medicare Fund: Trustees

Slower growth in U.S. healthcare spending and expected savings from Obamacare are shoring up the funding outlook for the federal Medicare program that covers the hospital bills of the elderly, trustees of the program said on Monday. The program’s trust fund for hospital care will run out of money in 2030, four years later than […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
Hand Hygiene Compliance Infeasible for Anesthesia Providers

Anesthesia providers had high numbers of hand hygiene (HH) opportunities in the operating room per hour, but low levels of HH compliance, according to a new study. Compliance was lowest during the first and last 20-minute periods in the operating room. “Complete compliance with HH practice as recommended by World Health Organization guidelines would have […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
FDA Approves Abuse-Deterrent Oxycodone/Naloxone Combo

The US Food and Drug Administration (FDA) has approved an abuse-deterrent extended-release formulation of oxycodone (Targiniq ER, Purdue Pharma LP), a combination of oxycodone hydrochloride and naloxone hydrochloride, the agency announced today. The new formulation is approved to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment, for which alternative treatment options are […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
Doctor Found Guilty of Manslaughter After Overdose Deaths

Stan Xuhui Li, MD, of Hamilton, New Jersey, was a full-time anesthesiologist at a local hospital who had a sideline. On weekends, the 60-year-old Dr. Li saw patients in a pain-management clinic 80 miles away in the Queens borough of New York City. A jury in a New York state court concluded on July 18 […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
How to coach your team to brilliance

Every leader is a coach to those who look to them for guidance. Your job as a leader is to be there when one of your employees are in a rut, but if you consistently offer them a gift-wrapped solution, those employees will forfeit their problem-solving skills in the process. Eventually, a new problem manifests […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
CMS Confirms ICD-10 Deadline

October 1st, 2015, is the deadline for healthcare providers to implement the twice-delayed ICD-10 code set, federal officials confirm. HHS will release the final rule, Administrative Simplification: Change to the Compliance Date for the International Classification of Diseases, 10th Revision (ICD–10–CM and ICD-10-PCS) Medical Data Code Sets, in the Federal Register August 4. The one-year […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer

Published in Oral Oncol. 2014 Jul 4. pii: S1368-8375(14)00172-9 Authors: Bossi P et al BACKGROUND: Painful mucositis is one of the most distressing toxicities of chemoradiotherapy (CRT) for head and neck cancer (HNC), with the characteristics of incidental predictable breakthrough pain (BTP) during swallowing. Fentanyl pectin nasal spray (FPNS) could be a good therapeutic option. […]

Read More
Uncategorized Published - 4 August, 2014    By - Dr. Clemens
Update on Tamper-Proof Hydrocodone Products

Abuse-deterrent single-entity hydrocodone products are edging closer to market. Purdue Pharma LP has announced that the US Food and Drug Administration (FD) has granted Priority Review designation for its once-daily single-entity hydrocodone bitartrate tablet, an investigational pain medication formulated to make the product more difficult to misuse or abuse though chewing, snorting, and intravenous injection. […]

Read More
Uncategorized Published - 2 August, 2014    By - Dr. Clemens
How to keep your employees from getting bored

These six tips will help you combat boredom in your workplace, too. 1. Teach people how to treat you As an executive or manager, if you micromanage and focus only on your specific tasks, your team will reflect and replicate that type of work environment, which can easily bore people. Keep people from falling into […]

Read More